Javed Butler MD, MPH, MBA, FACC, FAHA, FESCPatrick A. Leehan Professor and Chairman of the Department of Medicine Department at University of Mississippi, Jackson, Mississippi
Javed Butler, MD, MPH, MBA, is the Patrick A. Leehan Professor and Chairman of the Department of Medicine Department at University of Mississippi. He is also Professor of Physiology and Biophysics. Prior to joining the University of Mississippi, he was Charles A. Gargano Professor and Director of the Division of Cardiovascular Medicine and Co-Director of the Heart Institute at Stony Brook University, New York. He had served as the Director for heart failure research at Emory University and Director of the heart and heart-lung transplant programs at Vanderbilt University prior to that.
He received his medical degree from the Aga Khan University in Karachi, Pakistan. He then completed residency training at Yale University, cardiology fellowship and advanced heart failure and transplant fellowships at Vanderbilt University, and cardiac imaging fellowship at the Massachusetts General Hospital, Harvard Medical School in Boston, Massachusetts. He has completed Master of Public Health degree from Harvard University and Master in Business Administration from Emory University.
Dr. Butler is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure. He serves on several national committees for the American College of Cardiology, American Heart Association, and the National Institutes of Health, and serves on the Heart Failure Society of America Board of Directors. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.
Dr. Butler has authored more than 450 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals. He has been cited numerous times in America’s Best Doctors list.
Javed Butler has received research support from the National Institutes of Health, PCORI and the European Union; and serves as a consultant for Amgen, Array, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squib, CVRx, G3 Pharmacautical, Innolife, Janssen, Luitpold, Medtronic, Merck, Novartis, Relypsa, StealthPeptide, SC Pharma, Vifor, and ZS Pharma.
Recent Contributions to PracticeUpdate:
- Treatment of Heart Failure in an Era of Multiple Therapies
- Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
- Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes, Established Cardiovascular Disease, and Chronic Kidney Disease
- Exercise Echocardiography May Help Rule Out HFpEF